Celldex Therapeutics reported $-80.62M in Operating Profit for its fiscal quarter ending in June of 2026.





Operating Profit Change Date
AbbVie USD 6.72B 1.99B Jun/2026
Agenus USD 15.05M 656K Mar/2026
Amgen USD 4.61B 777M Jun/2026
Bristol-Myers Squibb USD 299M 3.07B Jun/2026
Celldex Therapeutics USD -80.62M 3.81M Jun/2026
Glaxosmithkline GBP 2.29B 3.08M Mar/2026
Nektar Therapeutics USD -38.26M 19.17M Mar/2026
Northwest Biotherapeutics USD -10.9M 3.42M Mar/2026
Pfizer USD 667M 4.32B Jun/2026
Rigel Pharmaceuticals USD 14.06M 13.61M Sep/2024
Roche Holding CHF 11.46B 1.91B Jun/2026